5-Amino-1MQ
Also known as: 5-Amino-1-methylquinolinium · 5A1MQ
A small molecule inhibitor of NNMT enzyme that boosts metabolism and promotes fat cell apoptosis. Shows promise as a novel anti-obesity agent in preclinical research.
Mechanism of Action
NNMT is an enzyme that suppresses the metabolic rate. 5-Amino-1MQ blocks NNMT, increases the NAD+/NADH ratio, activates SIRT1, and upregulates metabolic pathways leading to fat reduction.
Benefits
- Inhibits NNMT to boost resting metabolic rate
- Promotes fat cell shrinkage and apoptosis
- Increases NAD+ levels
- Potential for muscle sparing during weight loss
Side Effects & Risks
- Limited human data available
- Potential GI discomfort
Where to Buy 5-Amino-1MQ
3 options across 3 vendors · Sorted cheapest first · All include direct product link
From
$58.00
All links are affiliate links — PeptideWiki earns a commission at no extra cost to you. Coupon codes apply at checkout. Prices and availability may change. Always verify COA before purchasing.
Storage & Reconstitution Guide
Storage Temperature
-20°C (lyophilized)
24 months (lyophilized), 28 days (reconstituted)
Reconstitution Solvent
Bacteriostatic water (BAC water)
Swirl gently — do not shake or vortex
Handling Notes
Protect lyophilized peptide from moisture and light. Once reconstituted, keep refrigerated. Discard if solution becomes cloudy or discolored. Use insulin syringe for precise dosing.
Step-by-Step Reconstitution
Gather supplies
BAC water, insulin syringe, alcohol swabs, vial
Disinfect tops
Swab rubber stoppers of both vials with alcohol
Draw BAC water
Pull desired mL of BAC water into syringe
Inject slowly
Inject BAC water down the side of the peptide vial, swirl gently to dissolve
Research Protocol
- Dose Range
- 50–100 mg
- Frequency
- Once or twice daily oral
- Cycle
- 4-8 weeks
- Routes
- oral
- Notes
- Research compound with limited human clinical data.
Legal & Regulatory Status
Sold for research purposes only. Not for human use. Laws vary by country.
Commonly Stacked With
View all peptide stacks →External Resources
More in Weight Management
LY3437943
An emerging triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 3 clinical trials show unprecedented weight loss of up to 24% body weight.
AOD9604
A synthetic fragment of the C-terminus of HGH (amino acids 176-191) that retains the fat-burning properties of growth hormone without affecting blood sugar or IGF-1 levels.
Mitochondrial Open Reading Frame of the 12S rRNA-c
A mitochondria-derived peptide that acts as a metabolic regulator, improving insulin sensitivity, exercise capacity, and potentially mimicking caloric restriction.
Pancreatic peptide bioregulator
A synthetic pancreatic peptide bioregulator targeting pancreatic islet cell function. Normalizes insulin secretion, improves beta-cell function, and reduces pancreatic oxidative stress. Studied for type 2 diabetes prevention, metabolic syndrome, and pancreatic aging.